This project team will create a White Paper with recommendations for analyses and displays associated with Hepatotoxicity, with a focus on Phase 2-4 clinical trials and integrated submission documents
Project Leads:
Melvin Munsaka
-
melvin.munsaka@abbvie.com
Terry Walsh
-
terry.walsh@astellas.com